Category: CRO


Postcards from Bangalore 
Posted on Sep 10, 2015

  Last week, we had the good fortune of spending a week in India, along with our colleagues from Ventac Partners. Our trip took us through the cities of Mumbai, Pune, and Bangalore. Our main focus was a visit with a major client, a CDMO with multiple facilities across the country. Here are a few

Sandoz closes generic development center in India 
Posted on Dec 05, 2012

Last week, Sandoz announced they are closing a number of generic product development centers around the world, including the Sandoz Development Centre near Mumbai. A few items in this report caught our eye. First, this hat tip to the CRO industry: While a pharma industry expert said the closure of the development centre would mean

The Era of the One Man Pharma Band (With Updates) 
Posted on May 31, 2011

There is a fascinating discussion taking place over at Derek Lowe’s blog today on one-man drug companies: …some of them are not quite down to one person, but you can count the employees on your fingers. In all of these cases, everything is being contracted out. Aside from the samples given in the post, and

VCs Avoiding the Creep 
Posted on May 05, 2011

Today’s In Vivo Blog post summarizes comments that we have been hearing from our clients as well. Namely, that deals are increasingly shifting towards back-ended Royalties and earn-outs, at the expense of larger upfront payments. Companies are now facing an¬†interesting¬†dilemma. Suppose a company has a lead product candidate ready for Phase II clinical testing. One

Covance does it again…this time in Europe 
Posted on Sep 30, 2010

Today we hear the news that Covance has done it again. Today they acquired two European R&D sites from Sanofi for $25 million. In addition, Sanofi agreed to purchase R&D services from these facilities for up to $2.2 billion over 10 years. This follows a similar deal struck with Lilly in the US in 2008.

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.